{"id":"W2059079195","doi":"10.1185/03007995.2015.1027185","title":"Single-pill combination therapy for type 2 diabetes mellitus: linagliptin plus empagliflozin","year":2015,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Linagliptin; Empagliflozin; Medicine; Metformin; Type 2 diabetes; Type 2 Diabetes Mellitus; Pill; Glycemic; Diabetes mellitus; Dipeptidyl peptidase-4 inhibitor; Pharmacology; Internal medicine; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003090975,0.0003873984,0.001429219,0.0005186846,0.0001366005,0.00009752356,0.000270905,0.000384216,0.0001292924],"category_scores_gemma":[0.001897369,0.0002602713,0.0002339074,0.0005526721,0.0003010926,0.000080985,0.0002208368,0.0007643512,0.0001138499],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004180124,"about_ca_system_score_gemma":0.001044564,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002688734,"about_ca_topic_score_gemma":0.000001054881,"domain_scores_codex":[0.9959161,0.0003330866,0.0005620841,0.0006306712,0.001769499,0.0007885545],"domain_scores_gemma":[0.9970094,0.0008869194,0.000137915,0.0003894091,0.0006525339,0.0009238194],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008925638,0.000905407,0.00001531169,0.01540312,0.0002113476,0.00000342463,0.00003912212,4.416027e-9,1.096859e-7,0.0007996341,0.0466337,0.9358996],"study_design_scores_gemma":[0.002992828,0.004166005,0.000006908806,0.01923429,0.0001589135,0.000001352548,0.00001763863,0.00009559265,0.000002375509,0.0007093704,0.9724023,0.0002124493],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001083345,0.9929258,0.00002263607,0.0006442043,0.001779125,0.003851594,0.00002745133,0.0000630602,0.000577773],"genre_scores_gemma":[0.00003363945,0.9941903,0.00005739104,0.00003705136,0.001139442,0.0006616702,0.003108203,0.00005938625,0.0007128696],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9356871,"threshold_uncertainty_score":0.999985,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3692606348567541,"score_gpt":0.5114607009127419,"score_spread":0.1422000660559877,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}